J&J Shot Loses Antibody Protection Against Omicron In Study - NDTV
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
Johnson & Johnson's antibody protection looking particularly weak in the lab test.
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus varia… [+3140 chars]
Read More
Other Stories in Health
- Can gut microbes help prevent Alzheimer’s?
- Who really decides what Australians eat? New study reveals financial sector’s hidden power
- Genetic diversity of malaria parasite challenges one size fits all strategies
- How can chia seed water reduce belly fat?
- New fitness metric may predict heart disease risk better than steps or heart rate, finds study
- New assay detects epigenetic changes caused by carcinogenic chemicals
- Refining the diagnosis of large granular lymphocytic leukemias and their mimics
- Capturing the true meaning of quality in health services
- Akbar to Jahangir: How Mughal emperors used royal footwear to flaunt their power
.png)
